Armata Pharmaceuticals, Inc.
- Stock
- Ticker ARMP
- ISIN US04216R1023
- NYSE
Performance, volatility and drawdowns of Armata Pharmaceuticals, Inc. since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $343. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −99.0% in 04/2025, measured from the peak in 11/2016. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Operating income | -11 | -8.2 | -6.8 | -7.8 | -14 | -8.8 | -10 | -7.4 |
| EBITDA | -10 | -7.8 | -6.5 | -7.4 | -13 | -8.3 | -9.8 | -6.8 |
| Net income | 2.6 | -6.5 | -16 | -27 | -124 | -115 | 74 | 55 |
| Earnings per share | -0.29 | -0.20 | -0.45 | -0.74 | -3.43 | -3.16 | -0.27 | -0.24 |
| Balance sheet | ||||||||
| Total assets | 86 | 87 | 81 | 90 | 77 | 70 | 90 | 84 |
| Liabilities | 134 | 141 | 150 | 185 | 295 | 381 | 321 | 259 |
| Equity | -48 | -54 | -70 | -96 | -219 | -312 | -231 | -174 |
| Cash | 9.3 | 12 | 4.3 | 15 | 8.7 | 4.8 | 24 | 18 |
| Cash flow | ||||||||
| Operating cash flow | -7.9 | -7.6 | -7.2 | -4.3 | -6.7 | -5.8 | -8.7 | -5.5 |
| Capital expenditure | 0.1 | -0.1 | -0.1 | -0.2 | -0.1 | -0.1 | 0.0 | -0.1 |
| Free cash flow | -7.9 | -7.7 | -7.4 | -4.5 | -6.7 | -5.8 | -8.7 | -5.6 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2025 at +239.5%, weakest 2018 at −79.6%. 4 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 12 Nov 2026 | −$0.24 |
| 12 Aug 2026 | −$0.27 |
| 13 May 2026 | −$3.16 |
| 25 Mar 2026 | −$3.43 |
| 12 Nov 2025 | −$0.74 |
| 12 Aug 2025 | −$0.45 |
| 14 May 2025 | −$0.20 |
| 21 Mar 2025 | −$0.29 |
| 13 Nov 2024 | −$0.15 |
| 13 Aug 2024 | −$0.25 |
| 7 May 2024 | −$0.69 |
| 21 Mar 2024 | −$0.55 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €102m
- Market cap in trading currency
- $113m
- Enterprise value
- $94.4m
- P/E
- –
- P/S
- –
- P/B
- –
- EV/Sales
- –
- EV/EBITDA
- –
- Earnings yield
- –
- FCF yield
- -23.8%
Results (last four quarters)
- Revenue
- –
- Gross profit
- –
- EBITDA
- −$38.3m
- Net income
- −$111m
- Earnings per share
- −$7.10
- Revenue per share
- –
- Revenue growth
- –
- Earnings growth
- –
Profitability
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity
- –
- Return on assets
- -131.0%
Balance sheet and cash flow
- Cash
- $18.3m
- Cash per share
- $0.49
- Financial debt
- –
- Debt/equity %
- –
- Current ratio
- 0.12
- Book value per share
- −$4.68
- Operating cash flow
- −$26.6m
- Free cash flow
- −$26.9m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 37.2m
- Volume
- 85,636
- Avg. volume 3 months
- 182,804
- Relative volume
- 0.5
Price and technicals
- Price
- $3.03
- 1 day
- +1.7%
- 52-week high
- $14.80
- 52-week low
- $2.66
- Distance to 52-week high
- −79.5%
- Distance to 52-week low
- +13.9%
- Distance to 50-day line
- −14.4%
- Distance to 200-day line
- −55.2%
- RSI (14)
- 45
- Volatility 1M
- 154.1%
Performance
- 1 week
- −21.7%
- 1 month
- −12.2%
- 3 months
- −41.4%
- 6 months
- −63.8%
- YTD
- −51.8%
- 1 year
- −58.5%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has ARMP performed since 11/2016?
$10,000 grew to $343 by 20 Nov 2026, which is −28.6% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is ARMP?
Volatility was 96.6% per year, measured on monthly returns. The largest decline from a peak was −99.0%, with the low in 04/2025.
How does ARMP compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, ARMP returned −28.6% at 96.6%. The correlation of monthly returns was 0.24; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.